Comments
Glaxo melanoma drugs beat chemo in pivotal trials
05.06.2012. | CHICAGO (Reuters) - Late-stage trials of two experimental skin cancer drugs from GlaxoSmithKline, each designed to block different pathways used by tumor cells, have found the drugs helped patients with fewer side effects than current chemotherapy....
